scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1001421005 |
P356 | DOI | 10.1007/BF01314726 |
P698 | PubMed publication ID | 6293410 |
P2093 | author name string | W K Chong | |
T R Doel | |||
P2860 | cites work | Antibody response to viral antigens. | Q39938393 |
Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease | Q39987220 | ||
Biochemical Mapping of the Foot-and-Mouth Disease Virus Genome | Q40079325 | ||
Stability and immunogenicity of empty particles of foot-and-mouth disease virus | Q40214915 | ||
Morphogenesis of foot-and-mouth disease virus. I. Role of procapsids as virion Precursors | Q40254358 | ||
A Comparative Chemical and Serological Study of the Full and Empty Particles of Foot-and Mouth Disease Virus | Q40312952 | ||
A 65 S PARTICLE CONTAINING VIRAL PROTEIN IN CELLS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS. | Q45712931 | ||
Qualitative assessment of 146 S particles of foot-and-mouth disease virus in preparations destined for vaccines | Q45800162 | ||
Thermal stability of foot-and-mouth disease virus | Q45800767 | ||
Chemical and physical properties of foot-and-mouth disease virus: a comparison with Maus Elberfeld virus | Q45820402 | ||
A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure | Q45823495 | ||
Further evidence for multiple proteins in the foot-and-mouth disease virus particle | Q45827343 | ||
P433 | issue | 2 | |
P921 | main subject | foot-and-mouth disease virus | Q1911079 |
foot-and-mouth disease | Q152401 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 185-191 | |
P577 | publication date | 1982-01-01 | |
P1433 | published in | Archives of Virology | Q2860564 |
P1476 | title | Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus | |
P478 | volume | 73 |
Q39578733 | Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins |
Q40111517 | Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction |
Q89712313 | Biocompatible cationic solid lipid nanoparticles as adjuvants effectively improve humoral and T cell immune response of foot and mouth disease vaccines |
Q102142372 | Characterization and stabilization in process development and product formulation for super large proteinaceous particles |
Q33537528 | Characterization of foot-and-mouth disease virus antigen by surface-enhanced laser desorption ionization-time of flight-mass spectrometry in aqueous and oil-emulsion formulations |
Q44643781 | Chitosan-based systems for intranasal immunization against foot-and-mouth disease. |
Q40461832 | Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus. |
Q40592868 | DNA vaccine (P1-2A-3C-pCDNA) co-administered with Bovine IL-18 gives protective immune response against Foot and Mouth Disease in cattle. |
Q91621211 | Development of GEM-PA-nanotrap for purification of foot-and-mouth disease virus |
Q42282512 | Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for seromonitoring vaccinated animals |
Q40015542 | Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus |
Q83400965 | Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles |
Q92408035 | Engineering viable foot-and-mouth disease viruses with increased acid stability facilitate the development of improved vaccines |
Q47590462 | Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine |
Q90163207 | Evaluation of Quality Control Methods for Foot-And-Mouth Disease Vaccines by High-Performance Liquid Chromatography |
Q35044859 | FMD vaccines |
Q45399254 | Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs |
Q45365896 | Foot and mouth disease (FMD) virus: quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography |
Q42177158 | Foot-and-mouth disease vaccination induces cross-reactive IFN-γ responses in cattle that are dependent on the integrity of the 140S particles |
Q42253346 | Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves |
Q40433851 | Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. |
Q45738400 | Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs |
Q91941540 | Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability |
Q34661842 | Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles |
Q91935369 | Inherent biophysical stability of foot-and-mouth disease SAT1, SAT2 and SAT3 viruses |
Q40061913 | Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control. |
Q54377073 | Microvascular endothelial cells play potential immunoregulatory roles in the immune response to foot-and-mouth disease vaccines. |
Q89518630 | Negatively charged amino acids at the foot-and-mouth disease virus capsid reduce the virion-destabilizing effect of viral RNA at acidic pH |
Q40664785 | Novel 6xHis tagged foot-and-mouth disease virus vaccine bound to nanolipoprotein adjuvant via metal ions provides antigenic distinction and effective protective immunity |
Q45394711 | Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and A and their potential use in quantification of intact virus for vaccine manufacture |
Q44397703 | Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type 'O' produced in Pichia pastoris |
Q35941324 | Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves |
Q38744534 | SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability |
Q39079735 | Selection and characterization of an acid-resistant mutant of serotype O foot-and-mouth disease virus |
Q39002258 | Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus |
Q40273752 | Stabilization study of inactivated foot and mouth disease virus vaccine by size-exclusion HPLC and differential scanning calorimetry |
Q42150623 | Stabilizing effects of excipients on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles during storage as oil-emulsion vaccine |
Q27702186 | Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design |
Q39891157 | Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs |
Q71275857 | The evaluation of a physical method for the quantification of inactivated poliovirus particles and its relationship to D-antigenicity and potency testing in rats |
Q45324143 | The pH stability of foot-and-mouth disease virus |
Q94539244 | The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine |
Q92340066 | Thermostability of the Foot-and-Mouth Disease Virus Capsid Is Modulated by Lethal and Viability-Restoring Compensatory Amino Acid Substitutions |
Q37403499 | Vaccination against foot-and-mouth disease virus: strategies and effectiveness |
Q92230485 | Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing |
Q39868443 | Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. |
Search more.